The CASSS Cell & Gene Therapy Products (CGTP) Symposium, held from June 11-13 in Rockville, Maryland, was an exceptional gathering for professionals dedicated to advanced therapies. The exchange of knowledge and expertise, coupled with the shared advancements in good science and CMC, significantly propelled the industry forward.

Dr. Jing Fan, the founder and CEO of Hopstem, delivered an informative presentation on "Stem Cell-derived Medicinal Products" Plenary Session, with a focus on "Development of Releasing Criteria and Potency Assays for an iPSC-Derived Neural Progenitor Cell Product Targeting CNS Diseases." During the panel discussion, Dr. Fan and other panelists, including Kevin Okimura from Orca Bio, Andreea Barbu from the Swedish Medical Products Agency, Saravanan Karumbayaram from CBER, FDA, and Todd McDevitt, Head of Cell Therapy at Genentech, shared their views on interesting questions raised by the Chair or the audience.

To learn more about the session and symposium, please check out:

https://virtual.oxfordabstracts.com/#/event/5244/program